Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Management of Lung Cancer Patients”

159 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 159 results

Not applicableUnknownNCT05314296
What this trial is testing

Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy

Who this might be right for
Non Small Cell Lung CancerT790MEGFR Gene Mutation
N.N. Blokhin National Medical Research Center of Oncology 70
Not applicableStudy completedNCT03379350
What this trial is testing

The Impacts of Intermittent Chest Tube Clamping on Chest Tube Drainage Duration and Postoperative Hospital Stay After Lung Cancer Surgery

Who this might be right for
Management of Lung Cancer Patients
Wu Nan 180
Not applicableStudy completedNCT04802902
What this trial is testing

Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting

Who this might be right for
Bronchial Cancer
Centre Hospitalier de PAU 10
Early research (Phase 1)Active Not RecruitingNCT03546361
What this trial is testing

CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 24
Post-approval studies (Phase 4)Ended earlyNCT05834569
What this trial is testing

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

Who this might be right for
DeliriumAgedLung Neoplasms+2 more
Korea University Guro Hospital 25
Testing effectiveness (Phase 2)Study completedNCT00998192
What this trial is testing

REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung

Who this might be right for
Metastatic or Recurrent Squamous Cell Carcinoma of the Lung
Oncolytics Biotech 32
Early research (Phase 1)Study completedNCT01766739
What this trial is testing

Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 18
Not applicableStudy completedNCT04836975
What this trial is testing

Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:

Who this might be right for
Lung Cancer
AstraZeneca 45
Large-scale testing (Phase 3)Study completedNCT00718315
What this trial is testing

Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 201
Not applicableStudy completedNCT03717402
What this trial is testing

Smartphone Technology to Alleviate Malignant Pain (STAMP)

Who this might be right for
CancerPain ManagementOpioid Use
Dana-Farber Cancer Institute 20
Not applicableNot Yet RecruitingNCT06930313
What this trial is testing

Compassion-Based Intervention for Lung Cancer Caregivers (CBI-LCC)

Who this might be right for
Compassion
Taipei Medical University 84
Testing effectiveness (Phase 2)WithdrawnNCT04576208
What this trial is testing

Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Takeda
Not applicableActive Not RecruitingNCT07389642
What this trial is testing

Brain Oligometastasis in NSCLC

Who this might be right for
Brain OligometastaticNon-small Cell Lung Cancer
University Hospital, Bordeaux 46
Not applicableStudy completedNCT04324437
What this trial is testing

ERAPID: Online Symptom Reporting in Lung Cancer

Who this might be right for
Thoracic CancerNon-small Cell Lung CancerSmall-cell Lung Cancer+1 more
University of Leeds 43
Not applicableLooking for participantsNCT05990946
What this trial is testing

Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer

Who this might be right for
Lung Neoplasms, Non-Small Cell Lung CancerPostoperative ComplicationsPatient Reported Outcome Measures+2 more
Zhongshan People's Hospital, Guangdong, China 736
Not applicableLooking for participantsNCT05731076
What this trial is testing

Self-Management Support for Lung Cancer Patients With Cachexia

Who this might be right for
Cachexia-Anorexia Syndrome
Changhua Christian Hospital 104
Not applicableActive Not RecruitingNCT05818449
What this trial is testing

Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)

Who this might be right for
Non-small Cell Lung Cancer Stage IV
University of Cologne 850
Early research (Phase 1)Study completedNCT04752215
What this trial is testing

A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface

Who this might be right for
Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Carcinoma, Hepatocellular, Head and Neck Neoplasms, Gastrointestinal Neoplasms
Boehringer Ingelheim 67
Not applicableLooking for participantsNCT07405931
What this trial is testing

Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients

Who this might be right for
Early Gastric CancerAdvanced Gastric CancerEarly Lung Cancer+5 more
Ulsan University Hospital 414
Not applicableLooking for participantsNCT05349227
What this trial is testing

Comprehensive Outcomes for After Cancer Health

Who this might be right for
Ovarian CancerBreast CancerLung Cancer+8 more
Pack Health 625
Load More Results